A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(7 sites)

United States

University of California Davis, Sacramento, California

UCHealth University of Colorado Hospital, Aurora, Colorado

University Of Iowa Hospitals And Clinics, Iowa City, Iowa

Mercy Medical Center, Baltimore, Maryland

Mayo Clinic, Rochester, Minnesota

The Vanderbilt Clinic, Nashville, Tennessee

Liver institute Northwest, Seattle, Washington